Back to KROS
NORTHERN TRUST CORP KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
15
Latest value
$14K
Q3 2026
Peak value
$4.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $85K |
| Q4 2025 | $64K |
| Q4 2025 | $4.9M |
| Q4 2025 | $84K |
| Q4 2025 | $6K |
| Q1 2026 | $46K |
| Q1 2026 | $34K |
| Q1 2026 | $2.7M |
| Q1 2026 | $18K |
| Q2 2026 | $31K |
| Q2 2026 | $1.6M |
| Q2 2026 | $16K |
| Q3 2026 | $29K |
| Q3 2026 | $1.7M |
| Q3 2026 | $14K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $14K | 1.2K | — | — |
| Q3 2026 | $1.7M | 148.1K | — | — |
| Q3 2026 | $29K | 2.5K | — | — |
| Q2 2026 | $16K | 1.5K | — | — |
| Q2 2026 | $1.6M | 149.4K | — | — |
| Q2 2026 | $31K | 2.9K | — | — |
| Q1 2026 | $18K | 1.7K | — | — |
| Q1 2026 | $2.7M | 245.2K | — | — |
| Q1 2026 | $34K | 3.1K | — | — |
| Q1 2026 | $46K | 4.2K | — | — |
| Q4 2025 | $6K | 273 | — | — |
| Q4 2025 | $84K | 4.1K | — | — |
| Q4 2025 | $4.9M | 238.8K | — | — |
| Q4 2025 | $64K | 3.1K | — | — |
| Q4 2025 | $85K | 4.2K | — | — |